共 259 条
[1]
Scirica BM(2016)Summary of revisions Diabetes Care 39 S4-S5
[2]
Kim HC(2017)Use of biomarkers in predicting the onset, monitoring the progression, and risk stratification for patients with type 2 diabetes mellitus Clin Chem 63 186-195
[3]
Greenland P(2010)Multimarker prediction of coronary heart disease risk: The Women’s Health Initiative J Am Coll Cardiol 55 2080-2091
[4]
Rossouw JE(2018)Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes Clin Transl Med 7 9-145
[5]
Manson JE(2003)Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A Biochem J 376 135-366
[6]
Cochrane BB(2003)The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification J Clin Invest 112 357-1455
[7]
Lasser NL(1993)Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level Mol Endocrinol 7 1445-1767
[8]
Maruo S(2006)Association between human fetuin-A and the metabolic syndrome Data from the Heart and Soul Study. Circulation 113 1760-188
[9]
Mori K(2008)Fetuin-A and incident type 2 diabetes mellitus in older persons JAMA 300 182-833
[10]
Motoyama K(2003)Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Lancet 361 827-2562